Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of Apexigen, Inc. to Pyxis Oncology, Inc. . Under the. -Today at 02:57 pm- MarketScreener
Pyxis Oncology to Present at BTIG Virtual Biotechnology Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr Lara Sullivan tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Prometheus Biosciences (NASDAQ:RXDX – Free Report) and Pyxis Oncology (NASDAQ:PYXS – Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation. Insider and Institutional Ownership 92.7% of Prometheus Biosciences shares are […]
Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) shares shot up 3.5% on Monday . The stock traded as high as $2.66 and last traded at $2.65. 146,968 shares changed hands during mid-day trading, a decline of 93% from the average session volume of 2,043,548 shares. The stock had previously closed at $2.56. Analyst Upgrades and […]